5 unknown, 4 completed, 1 enrolling by invitation, 1 recruiting. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Unknown 5, Completed 4, Enrolling by invitation 1, Recruiting 1 |
Follow Fluorometholone: new trials by email Literature Review of Fluorometholone trials Research Report on Fluorometholone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vevye + Flarex Combination Therapy for Dry Eye Vevye(Cyclosporine 0.1% Ophthalmic Solution), Flarex - Dry Eye | Phase 4 | Enrolling by invitation | Canyon City Eyecare | 60 | 2026-04-03 | 2026-04-28 |
| Efficacy of NSAID vs. Steroid-NSAID Combo Post-Selective Laser Trabeculoplasty: Phase 4, Single-Center RCT Ketorolac 0.5% Eye Drops, Ketorolac 0.5% and Fluorometholone 0.1% Eye Drops - Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Unknown | St. Joseph's Healthcare Hamilton | 126 | 2024-09-01 | 2024-07-12 |
| The OPTIMISE Study Fluorometholone 0.1% Oph Susp, Dexamethasone 0.1% ophthalmic suspension, Stop steroids - Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy | Phase 4 | Recruiting | Maastricht University Medical Center | 342 | 2024-07-29 | 2025-10-06 |
| Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid Arthritis SYSTANE™ Hydration Lubricant Eye Drops - Dry Eye Syndromes | Phase 4 | Unknown | Chang Gung Memorial Hospital | 40 | 2024-02-05 | 2024-02-06 |
| Comparison of the Postoperative Use of Dextenza vs a Standard Regimen After PRK Dextenza 0.4Mg Ophthalmic Insert, Topical Fluorometholone - Steroid Ophthalmic Insert | Phase 4 | Unknown | Navy Medical Center San Diego | 60 | 2022-10-01 | 2022-10-20 |
| Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye Disease Fluorometholone 0.1% ophthalmic solution, Cyclosporine 0.05% eye drops - Dry Eye Disease (DED) | Phase 4 | Completed | Korea University Anam Hospital | 32 | 2022-09-01 | 2025-03-14 |
| Tolerability Comparison of Flarex to Lotemax SM Fluorometholone Acetate Ophthalmic Suspension 0.1%, Loteprednol Etabonate Ophthalmic Gel 0.38% - Ocular Inflammation, Keratoconjunctivitis | Phase 4 | Completed | Harrow Inc | 40 | 2021-05-01 | 2026-09-22 |
| Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy Fluorometholone, Functional Slit-Lamp Biomicroscopy - Dry Eye Syndromes, Inflammation | Phase 4 | Unknown | Zhongshan Ophthalmic Center, Sun Yat-sen University | 20 | 2017-06-30 | 2018-11-20 |
| Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study Fluorometholone(FML), Loteprednol (Lotemax) - Must be PRK Candidate | Phase 4 | Unknown | Dr Salouti Eye Research Center | 200 | 2017-04-01 | 2016-11-28 |
| Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis FLUCON®, Cyclosporine A eye drops 0.5% - Adenoviral Keratoconjunctivitis | Phase 4 | Completed | Military Hospital of Tunis | 51 | 2017-04-01 | 2020-05-07 |
| Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery 0.1 % Dexamethasone, 0.1% Fluorometholone, 1% Rimexolone - Intraocular Pressure | Phase 4 | Completed | Cairo University | 40 | 2015-10-01 | 2016-06-29 |
Dry Eye Syndromes (5) · Corneal Diseases (2) · Arthritis, Rheumatoid (1) · Fuchs' Endothelial Dystrophy (1) · Glaucoma, Open-Angle (1) · Inflammation (1) · Keratoconjunctivitis (1) · Ocular Hypertension (1) · Postoperative Complications (1) · Strabismus (1)
Cairo University (1) · Canyon City Eyecare (1) · Chang Gung Memorial Hospital (1) · Dr Salouti Eye Research Center (1) · Harrow Inc (1) · Korea University Anam Hospital (1) · Maastricht University Medical Center (1) · Military Hospital of Tunis (1) · Navy Medical Center San Diego (1) · St. Joseph's Healthcare Hamilton (1) · Zhongshan Ophthalmic Center, Sun Yat-sen University (1)
United States (2) · Canada (1) · China (1) · Egypt (1) · Netherlands (1) · South Korea (1) · Taiwan (1) · Tunisia (1)
Afef Maalej (1) · Chi-Chin Sun, M.D/Ph.D (1) · Enitan A Sogbesan, MD (1) · Joshua Davidson, OD, FAAO (1)